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Canine babesiosis is a frequent and clinically significant tick-borne dis-
ease. Sixty symptomatic dogs with clinical findings compatible with babesiosis 
were included in this study conducted in Serbia. After clinical examination, blood 
samples were taken for microscopic examination, complete blood count (CBC), 
Canine SNAP 4Dx Test, DNA analyses and sequencing. The main clinical signs 
included apathy, anorexia, fever, brown/red discoloration of urine, pale mucous 
membranes, icterus, splenomegaly, and vomiting. The main clinicopathological 
findings in Babesia infections were a slight to severe thrombocytopenia and a 
mild to very severe normocytic normochromic anaemia. Microscopic evaluation 
revealed 58 positive samples with the presence of large and small intraerythro-
cytic piroplasms in 57 and 1 sample(s), respectively. No co-infections were found 
using SNAP test. Two Babesia species, B. canis (58/60) and B. gibsoni (2/60), 
were differentiated by polymerase chain reaction–restriction fragment length 
polymorphism (PCR-RFLP). Species identification was further confirmed by se-
quencing PCR products of B. gibsoni samples and six randomly selected B. canis 
samples. All dogs were treated with imidocarb dipropionate (6.6 mg/kg of body 
weight), given intramuscularly twice at an interval of 14 days. This report pre-
sents the first molecular evidence of the occurrence of B. gibsoni and B. canis, 
confirmed by DNA sequencing, in sick dogs from Serbia.  
Key words: Babesia canis/gibsoni, dogs, clinical signs, PCR-RFLP, se-
quencing, Serbia 
Canine babesiosis is a frequent protozoan tick-borne disease with world-
wide distribution and global significance (Irwin, 2009; Solano-Gallego and 
Baneth, 2011). Causative agents of canine babesiosis (piroplasmosis) are in-
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traerythrocytic protozoa of the genera Babesia and Theileria (Irwin, 2009). The 
clinical manifestations of disease can vary from subclinical to severe or fatal. 
The severity of the disease depends on the species involved, the age and immune 
status of the host, and concurrent infections (Irwin, 2009). Clinical signs include 
pale mucous membranes, fever, anorexia, lethargy, splenomegaly, hypotension 
and water hammer pulse (Matijatko et al., 2012). Four species that can cause 
Babesia infection have been identified by molecular studies undertaken in 
Europe so far: Babesia canis, B. vogeli, B. gibsoni and B. microti-like, also 
known as Theileria annae or Babesia sp. ‘Spanish dog’ (Solano-Gallego and 
Baneth, 2011; Matijatko et al., 2012). Predominant vectors for the above-
mentioned species are Dermacentor reticulatus (B. canis), Rhipicephalus san-
guineus (B. vogeli), Haemaphysalis longicornis (B. gibsoni) and the main candi-
date vector of B. microti-like is Ixodes hexagonus (Solano-Gallego and Baneth, 
2011). There are some reports suggesting that direct dog to dog transmission, via 
bite wounds, is highly likely and might possibly be the main mode of transmis-
sion of B. gibsoni (Jefferies et al., 2007; Yeagley et al., 2009). Also, it has been 
demonstrated that B. gibsoni infection can be transmitted transplacentally (Fu-
kumoto et al., 2005). 
For many years, Babesia has been detected using stained blood smears as 
a standard diagnostic technique. Size and morphology of the intraerythrocytic pi-
roplasm have been the main parameters in diagnosing Babesia spp. However, 
some Babesia species that lead to different clinical manifestations cannot be 
morphologically distinguished (Kjemtrup et al., 2000; Jefferies et al., 2007). 
These Babesia species can be differentiated by molecular methods and not by the 
blood smear method (Criado-Fornelio et al., 2003). Moreover, molecular meth-
ods have other significant advantages, i.e. higher sensitivity and specificity, over 
the evaluation of peripheral blood smears for detecting canine babesiosis (Bashi-
ruddin et al., 1999). Analyses of DNA sequences are extremely useful in species 
identification, and the PCR-RFLP technique is faster, more affordable and thus 
often used in routine molecular identification of unicellular protozoan parasite 
species (Solano-Gallego et al., 2008; Stevanovic et al., 2011; Stevanovic et al., 
2013). It is important for veterinary science to track the prevalence and clinico-
pathological aspects of Babesia species infecting dogs around the world. 
Effective management of dogs with piroplasmosis involves both specific 
and supportive treatment. Large forms of Babesia are commonly treated with 
imidocarb dipropionate with good clinical response, while small forms of Babe-
sia appear to be more difficult to treat and imidocarb is less effective (Solano-
Gallego and Baneth, 2011). Diminazene aceturate used for the treatment of infec-
tions by both large and small Babesia spp. has a relatively narrow dose safety 
margin, it is also relatively toxic, and severe side effects have been reported fol-
lowing its use (Miller et al., 2005; Sakuma et al., 2009). Alternative therapy with 
the combination of the anti-malarial atovaquone and the macrolide azithromycin 
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has been recommended for the treatment of Babesia gibsoni infection (Birken-
heuer et al., 2004). The aim of supportive treatment is to restore adequate tissue 
oxygenation by the correction of anaemia and through rehydration. Prevention is 
very important when it comes to babesiosis and it requires dogs to be kept free of 
tick exposure (collars, spot-on formulations or sprays), to avoid fighting with 
other dogs, and any blood transfusions should be carefully screened to ensure the 
absence of pathogens (Irwin, 2009). 
To date, no data on molecular detection or genetic characterisation of 
Babesia species in dogs have been documented for Serbia. There is no informa-
tion about the epidemiology of canine babesiosis in Serbia either. The aim of this 
study was to identify the species responsible for canine babesiosis in Serbia, as 
well as to monitor clinical manifestations and some clinical findings of dogs with 
Babesia canis or B. gibsoni infection. 
 
 
Materials and methods 
Dogs, samples and laboratory tests 
Sixty symptomatic dogs with clinical findings compatible with babesiosis 
were studied from November 2012 to January 2014. All dogs were admitted to 
the Teaching Hospital at the Faculty of Veterinary Medicine in Belgrade for 
medical consultation and assistance. All relevant data (e.g. age, breed, gender, 
history of previous tick infestation, major clinical signs) of the patients were col-
lected and recorded by the veterinarians during clinical examination. All dogs 
were from the Belgrade area and had no recorded history of travelling outside 
Serbia. 
Venous blood samples were collected into sterile tubes with anticoagulant 
(EDTA) by cephalic venipuncture. Complete blood count (CBC) was performed 
by IDEXX ProCyte Dx (IDEXX Laboratories, USA). Dogs were considered 
anaemic when the haematocrit was lower than 37%. The severity of anaemia was 
classified as described elsewhere (Weiss and Tvedten, 2012). Thrombocytopenia 
was classified as slight (142–100 × 109 platelets/L), mild (99–50 × 109 plate-
lets/L), moderate (49–25 × 109 platelets/L) and severe (< 25 × 109 platelets/L) 
(Furlanello et al., 2005). 
Thin smears were prepared from blood taken from ear punctures of all 
dogs, stained with Diff-Quick®-type stain (Medion Diagnostics GmbH, Düdin-
gen, Switzerland) and examined by light microscopy for the evidence of possible 
intraerythrocytic piroplasms. All the blood samples were tested by Canine SNAP 
4Dx Test (Canine Heartworm Antigen – Anaplasma phagocytophilum – Borrelia 
burgdorferi – Ehrlichia canis Antibody Test Kit, IDEXX Laboratories, Inc., 
USA). 
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DNA extraction, PCR and RFLP-PCR 
DNA was isolated from the blood samples using QIAamp DNA Blood 
Mini Kit (Qiagen) according to the manufacturer’s recommendations. To detect 
Babesia parasites, all samples were subjected to PCR using primers PIRO-A (5’-
AATACCCAATCCTGACACAGGG-3’) and PIRO-B (5’-TTAAATACGAAT 
GCCCCCAAC-3’) designed to amplify a specific fragment of approximately 
410 bp of the 18S-rRNA gene of Babesia spp. (Olmeda et al., 1997). All PCRs 
were performed using a Multigene Gradient Thermal Cycler (Labnet Interna-
tional Inc.) in 25-μL volumes containing 1 × PCR buffer (Kapa Biosystems), 
1.5 mM MgCl2 (Kapa Biosystems), 100 μM dNTP (Kapa Biosystems), 2 μM of 
each primer, 0.5 U of Taq polymerase (Kapa Biosystems) and 5 μL of template 
DNA. The PCR parameters for amplification were as follow: initial DNA dena-
turation of 3 min at 95 °C followed by 40 cycles of 30 s at 94 °C, 30 s at 62 °C 
and 1 min at 72 °C, and terminated with a final extension step at 72 °C for 7 min. 
Amplification products were separated on a 2% agarose gel stained with ethidium 
bromide and visualised under UV light. A commercial O’RangeRulerTM 100 bp 
DNA Ladder (Fermentas) was used as a size marker. 
PCR-RFLP method by Solano-Gallego et al. (2008) was applied to differ-
entiate Babesia species. Digestion of PCR products with TaqI and HinfI enzymes 
(Thermo Scientific) was performed according to the manufacturer’s instructions. 
RFLP products were separated on a 3% agarose gel stained with ethidium bro-
mide and visualised under UV light. 
To confirm the PCR-RFLP results, all B. gibsoni and 6 randomly selected 
B. canis PCR products were directly sequenced in two directions using the Big-
Dye® Terminator method in an ABI 3730XL automatic DNA sequencer (Macro-
gen Europe, The Netherlands). Sequence similarity analysis was performed using 
the BioEdit version 7.2.5 and Clustal W software. Sequence homology searches 
were made using the online version of BLAST software (available at 
http://blast.ncbi.nlm.nih.gov). Finally, the representative sequences were depos-
ited in GenBank (accession numbers for B. gibsoni: KJ696716, KJ696717; acces-
sion numbers for B. canis: KJ696714, KJ696715). 
 
 
Results 
Clinical data 
Babesiosis was more frequently detected in males than in females (80% 
and 20%, respectively). The youngest infected dog was 2.5 months old and the 
oldest was 13 years old. Sixty-seven percent of reported canine babesiosis cases 
were young and middle-aged dogs (less than 5 years old). Various breeds were 
represented. The disease was more often diagnosed in purebred dogs (81.7%). 
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Both B. gibsoni infected dogs were of fighting breeds. Ticks were found on 33 of 
the dogs (55%) during clinical examination or earlier by the owner. In 12 cases 
(20%) dog owners reported prevention against ticks as follows: seven dogs were 
treated with permethrin-based spot-on products, four of them with fipronil-based 
spot-on formulations, and one dog had a collar with deltamethrin. 
According to the owners’ assessments, the time span between the onset of 
clinical signs and arrival at the clinic varied from one to seven days. Routine 
physical examination of the dogs revealed clinical signs compatible with babe-
siosis: apathy (98%), anorexia (88.3%), fever (78.3%), brown/red discoloration 
of urine (51.7%), pale mucous membranes (50%), icterus (28.3%), splenomegaly 
(28.3%), vomiting (26.7%), modified faeces (11.7%) and ataxia (6.7%). 
Thrombocytopenia was present in 59/60 (98.3%) and classified as slight in 
4/60 (6.7%), mild in 5/60 (8.3%), moderate in 7/60 (11.7%) and severe in 43/60 
(71.7%). Anaemia was present in 32/60 (53.3%) and further classified as mild in 
9/60 (15%), moderate in 10/60 (16.7%), severe in 9/60 (15%) and very severe in 
4/60 (6.67%). In the majority of cases, the anaemia was normocytic and normo-
chromic. Forty-three out of 60 (71.7%) dogs had lymphopenia, 19/60 (31.7%) 
leukopenia and 10/60 (16.7%) neutropenia. Leukocytosis was present in six dogs 
(10%) and neutrophilia in seven (11.7%). 
Blood smears and snap test 
Intraerythrocytic large, pear-shaped forms morphologically compatible 
with Babesia spp. were observed in the stained blood smears of 57 dogs (57/60, 
95%). In one case (1/60, 1.67%) much smaller oval or signet ring-shaped in-
traerythrocytic parasites were detected in thin blood smears. No co-infections 
were detected using Canine SNAP 4Dx Test. 
Molecular analysis 
Sixty blood samples from dogs with clinical signs suggestive of canine 
babesiosis were analysed using the molecular method. All blood samples were 
positive in the Babesia genus-specific PCR. RFLP analysis showed that 58 blood 
samples (96.7%) had restriction profiles similar to B. canis, and two samples 
were similar to B. gibsoni (3.3%). No case of B. vogeli was found. 
Results of the sequence analysis demonstrated 100% correspondence to 
PCR-RFLP-diagnosed Babesia species. The sequences obtained from all eight 
dogs were 100% homologous to sequences from B. canis and B. gibsoni present 
in GenBank. Four B. canis sequences were found to be identical with the 18S 
rRNA GenBank-deposited gene sequences of B. canis of dogs originating from 
France (GenBank accession no. KC902833.1), Hungary (DQ181653.1), Poland 
(AY321119.1), Croatia (AY072926.1), Russia (AY962187.1), and two B. canis 
sequences were found to be identical with the gene sequences of B. canis of dogs 
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originating from Turkey (KF499115.1), Romania (HQ662634.1), Russia 
(AY649326.1) and Hungary (DQ181656.1). 
Two B. gibsoni 18S rDNA partial sequences showed the highest similarity 
(100% correspondence) with sequences obtained from naturally infected dogs in 
India (GenBank accession no. KF878947.1), China (HG328237.1), Saint Kitts 
and Nevis (JX112784.1), Japan (AB478330.1), Taiwan (FJ769388.1), USA 
(EU084677.1), Australia (AY102164.1) and Spain (AY278443.1). 
Therapy and outcome 
All dogs with diagnosed babesiosis in this study received a specific treat-
ment with imidocarb dipropionate given by deep intramuscular injection in a 
dose of 6.6 mg/kg body weight. The same treatment was repeated after two 
weeks. The mortality rate of dogs infected with B. canis was 8.62%, and that of 
dogs infected with B. gibsoni was 50%. 
 
 
Discussion 
This is the first report of molecular detection of Babesia canis and B. gib-
soni in naturally infected dogs from Serbia. This study also presents the first evi-
dence of B. gibsoni in Serbia confirmed through DNA sequencing. Such results 
provide important information for both Serbia and Europe regarding the occur-
rence of B. gibsoni. 
Several Babesia species can infect dogs all over Europe and produce dif-
ferent clinical signs. Babesia canis is the most commonly found species in tem-
perate regions of Europe. Several studies have detected this species in dogs from 
Hungary, Croatia, Italy, Poland, Spain, Switzerland, Portugal, Russia, Germany, 
Slovenia, France, Albania, the Netherlands, Norway (Solano-Gallego and 
Baneth, 2011) and Romania (Ionita et al., 2012). Babesia gibsoni infection has 
been described in some European countries using molecular methods: two dogs 
in Germany (Hartelt et al., 2007), four in Spain (Criado-Fornelio et al., 2003; 
Tabar et al., 2009), one dog in Italy (Trotta et al., 2009), 14 dogs in Romania 
(Imre et al., 2013) and six from Croatia were diagnosed with B. gibsoni subclini-
cal infection (Beck et al., 2009). Our results support previous findings reported 
from neighbouring countries that B. canis is considered the main species which 
causes canine babesiosis in this part of Europe. 
The clinical manifestations of canine babesiosis reported in this study are 
very similar to those described in other European countries. Babesiosis in Serbia 
occurred more often in males (80%) than in females (20%), which is consistent 
with previous reports from other countries (Máthé et al., 2006; Adaszek et al., 
2011; René-Martellet et al., 2013). The obvious dominance of male dogs among 
our patients can be explained probably by the dog-keeping habits and the over-
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representation of males in the population of dogs at risk rather than by true gen-
der predisposition. This study confirmed that young dogs are at greatest risk of 
canine babesiosis (Bourdoiseau, 2006; Adaszek et al., 2011; René-Martellet et 
al., 2013). In this study, babesiosis was diagnosed more often in purebred dogs 
than in mixed-breed dogs. However, babesiosis had not been associated with any 
particular breed but rather with the dogs’ living conditions and the nature of their 
work (Bourdoiseau, 2006). 
The main clinicopathological findings in Babesia infections described in 
the present study were slight to severe thrombocytopenia, mild to very severe 
anaemia, lymphopenia and leukopenia. These results correspond well to the ab-
normalities reported previously (Furlanello et al., 2005; Zygner et al., 2007; So-
lano-Gallego et al., 2008). 
Bearing in mind that there were only two confirmed cases of B. gibsoni in 
Serbia so far (presented in this study), it is hard to make a comparative analysis 
of the clinical signs and findings in dogs infected with different Babesia species. 
This should be followed up in the future together with results of the therapy un-
dertaken. The absence of B. vogeli-infected dogs in this research may be ex-
plained by the fact that only animals with symptoms characteristic of babesiosis 
were examined, and that infection with this species usually takes a nearly or ab-
solutely asymptomatic course in adult immunocompetent dogs (Uilenberg et al., 
1989; Carret et al., 1999). 
In this study, Babesia infection was confirmed by both morphological and 
molecular detection methods in 58 cases. Small Babesia was proved to be B. gib-
soni, and all cases of large Babesia were B. canis. However, two dogs that had 
not been diagnosed with Babesia infection using light microscopy, were later 
confirmed to be infected by PCR, one with B. canis and the other with B. gib-
soni. This confirmed the higher sensitivity of molecular techniques in compari-
son with microscopic examination, as has been found previously (Macintire et 
al., 2002; Imre et al., 2013). 
Both cases of B. gibsoni infection detected in this study may be considered 
autochthonous because these animals had been born in Serbia and had never 
been taken abroad. The same refers to B. canis, whose presence was proven in 
vector species, D. reticulatus and D. marginatus, in Serbia (Mihaljica et al., 2012). 
Both B. gibsoni-infected dogs were of fighting breeds (American Stafford-
shire terrier and Tosa-Inu). Examination of the Tosa showed the presence of 
many scars on the head and neck, resulting from bite wounds. Despite the fact 
that the owner of the Tosa dog reported tick exposure a week before, these dog 
bites may be important from the epidemiological point of view because studies 
conducted in the United States (Yeagley et al., 2009) and Australia (Jefferies et 
al., 2007) indicated that direct dog-to-dog transmission is very likely, most nota-
bly through bite wounds. The other case was of a young, 11-month-old American 
Staffordshire terrier with no history of tick exposure. We tried to track down its 
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mother and siblings because transplacental transmission of B. gibsoni has been 
reported (Fukumoto et al., 2005) but without luck. 
The fact that 20% of infected dogs in this research contracted babesia de-
spite appropriate tick control by means of insecticide collars or spot-on prepara-
tions indicates that the prevention of canine babesiosis is not as easy as it may 
seen, nor is it always successful. The success of prevention is affected not only 
by the active substance but also by other factors which were not under our con-
trol: i.e. whether the composition is administered in the right dose and in the 
right way. The drug of choice for therapeutic treatment was imidocarb dipropi-
onate, the only drug approved for the treatment of canine babesiosis in Serbia. In 
B. gibsoni cases there was no time or need to try other therapeutic protocols, be-
cause one dog died shortly after the clinical examination and the other was better 
after therapy which included imidocarb dipropionate. In this study the mortality 
of dogs infected with B. canis reached 8.62%. Numerous studies on babesiosis 
caused by the same species, which were carried out in Europe, indicate that the 
mortality ranges from 1.5% to 20%, being the highest in Hungary (20%) (Máthé 
et al., 2006) and Croatia (11 to 13.9%) (Matijatko et al., 2009; Matijatko et al., 
2010; Crnogaj et al., 2010) and the lowest (1.5%) in France (Martinod et al., 
1986). However, due to the small number of dogs infected with B. gibsoni, to 
comment on the mortality rate in these animals is not justifiable. 
The clinicopathological findings are restricted to blood count alterations. 
Since biochemistry alterations were not studied, there is no information about 
possible organ dysfunctions. 
In conclusion, the results of this study confirm the presence of B. canis and 
B. gibsoni in symptomatic dogs from Serbia as well as the usefulness of PCR-
RFLP for precise identification of the causative species and for epidemiological 
studies. Examination of symptomatic dogs is of great importance, but asympto-
matic dogs should be examined as well. Fast and precise diagnostics allow us to 
start with adequate therapy on time and to prevent possible complications to the 
greatest possible extent. 
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